Govt to allow parallel submission of marketing, manufacturing approvals - Video
|
Overview
Through a recent Gazette Notification, the Ministry of Health and Family Welfare (MoHFW) has issued a draft of certain rule to amend the Drug Rules 1945 allowing parallel submission of application for grant of renewal of manufacturing and sales license serum, hormones, vaccines ,toxins, anti-toxins and other biological and special products, applications for grant of manufacturing permission for new drugs under the New Drugs and Clinical Trials Rules, 2019 and application for approval to manufacture new drug under rule 122B of the Drugs Rules.
For more details, check out the full story on the link below:
Govt To Allow Parallel Submission Of Marketing And Manufacturing Approvals
Speakers
Roshni Dhar, a Mass com graduate with a soft corner for health happenings, joined Medical Dialogues as a news anchor in 2021. Inspired by her mother who is a gynaecologist, she likes to keep herself and the world updated on the occurring in the medical field. She covers various aspects of health news for MDTV at Medical Dialogues. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751
